Serum chitotriosidase: a circulating biomarker in polycythemia vera-Reference-Cited by-同舟云学术

Serum chitotriosidase: a circulating biomarker in polycythemia vera

Published:2018-07-11 Issue:10 Volume:23 Page:793-802
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Krecak Ivan¹^ORCID,Gveric-Krecak Velka¹,Roncevic Pavle²,Basic-Kinda Sandra²,Gulin Josipa³,Lapic Ivana³^ORCID,Fumic Ksenija³⁴,Ilic Ivana⁵⁶,Horvat Ivana⁷,Zadro Renata⁴⁷,Holik Hrvoje⁸,Coha Bozena⁸,Peran Nena⁹,Aurer Igor²⁶,Durakovic Nadira²⁶^ORCID

Affiliation:

1. Department of Internal Medicine, General Hospital of Sibenik-Knin County, Sibenik, Croatia

2. Division of Hematology, Department of Internal Medicine, University Hospital Center Zagreb, Zagreb, Croatia

3. Division for Laboratory Diagnostics of Inborn Errors of Metabolism, Department of Laboratory Diagnostics, University Hospital Center Zagreb, Zagreb, Croatia

4. Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia

5. Department of Pathology and Cytology, University Hospital Center Zagreb, Zagreb, Croatia

6. School of Medicine, University of Zagreb, Zagreb, Croatia

7. Division for Laboratory Hematology and Coagulation, Clinical Department of Laboratory Diagnostics, University Hospital Center Zagreb, Zagreb, Croatia

8. Department of Internal medicine, “Dr. Josip Bencevic” General Hospital, Slavonski Brod, Croatia

9. Department of Laboratory Diagnostics, General Hospital of Sibenik-Knin County, Sibenik, Croatia

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10245332.2018.1498157

Reference91 articles.

1. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

2. A Gain-of-Function Mutation ofJAK2in Myeloproliferative Disorders

3. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis